FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2571259238> ?p ?o ?g. }

• W2571259238 endingPage "S491" @default.
• W2571259238 startingPage "S491" @default.
• W2571259238 abstract "Lung adenocarcinoma patients in advanced stage of disease that harbor EGFR sensitizing mutations are eligible for treatment with tyrosine kinase inhibitors (TKI) due to a high likelihood of response. Most patients will ultimately develop resistance at disease progression. The T790M mutation is a dominant resistance mechanism to TKI. EGFR plasma testing enables non-invasive monitoring and detection of T790M. We followed patients with EGFR sensitizing mutations by measuring EGFR mutations in plasma during TKI treatment. We analyzed patients who were diagnosed lung adenocarcinoma stage IV, detected EGFR sensitizing mutations in tumor tissue samples and treated with TKI at University Clinic Golnik. We collected baseline plasma samples prior to TKI treatment and consecutive plasma samples at different time intervals after initiation of therapy. At the beginning, two separate tests, cobas® EGFR Mutation Test for tissue (CE-IVD) and plasma (under development) were used, and since October 2015 one test for tissue and plasma, cobas® EGFR Mutation Test v2 (Roche, Pleasanton, CA, USA) is used. Detected EGFR mutations in plasma samples were expressed as semi-quantitative index (SQI) which reflects a proportion of mutated versus wild-type copies of the EGFR gene. During 2-year period we collected 414 peripheral blood samples from 63 patients and performed 619 EGFR plasma tests. There are 25 patients with baseline and serial follow-up EGFR plasma tests, 16 patients with only serial follow-up EGFR tests since they started with TKI treatment before EGFR plasma testing was available, 5 patients are included in adjuvant setting, and 17 patients had no monitoring due to various reasons. Maximum number of EGFR plasma tests done per patient was 27 at 20 time-points. When introducing EGFR plasma testing, we prepared two aliquots of plasma out of 10 ml blood sample in EDTA-tubes and run test for both aliquots. Results of reproducibility study showed 95% concordance rate between both aliquots and thus we modified protocol to run the second aliquot only if the first one was negative. At disease progression, reappearance of EGFR sensitizing mutations with increasing SQI levels was detected. In 14 patients who progressed we detected T790M mutation, in 10 of them during monitoring TKI treatment. We also observed daily variation in EGFR mutation levels in the plasma. These data support the value of EGFR plasma testing to monitor the patient's response to TKI and detect T790M resistance mutation prior to clinical progression in a routine clinical setting." @default.
• W2571259238 created "2017-01-13" @default.
• W2571259238 creator A5041297657 @default.
• W2571259238 creator A5058205936 @default.
• W2571259238 creator A5059795069 @default.
• W2571259238 creator A5063162309 @default.
• W2571259238 creator A5064357501 @default.
• W2571259238 creator A5067293324 @default.
• W2571259238 date "2017-01-01" @default.
• W2571259238 modified "2023-09-25" @default.
• W2571259238 title "P1.02-008 2-Year Single Institution Experience with EGFR Plasma Testing in Advanced NSCLC" @default.
• W2571259238 doi "https://doi.org/10.1016/j.jtho.2016.11.591" @default.
• W2571259238 hasPublicationYear "2017" @default.
• W2571259238 type Work @default.
• W2571259238 sameAs 2571259238 @default.
• W2571259238 citedByCount "0" @default.
• W2571259238 crossrefType "journal-article" @default.
• W2571259238 hasAuthorship W2571259238A5041297657 @default.
• W2571259238 hasAuthorship W2571259238A5058205936 @default.
• W2571259238 hasAuthorship W2571259238A5059795069 @default.
• W2571259238 hasAuthorship W2571259238A5063162309 @default.
• W2571259238 hasAuthorship W2571259238A5064357501 @default.
• W2571259238 hasAuthorship W2571259238A5067293324 @default.
• W2571259238 hasBestOaLocation W25712592381 @default.
• W2571259238 hasConcept C121608353 @default.
• W2571259238 hasConcept C126322002 @default.
• W2571259238 hasConcept C143998085 @default.
• W2571259238 hasConcept C146357865 @default.
• W2571259238 hasConcept C151730666 @default.
• W2571259238 hasConcept C2775999482 @default.
• W2571259238 hasConcept C2776256026 @default.
• W2571259238 hasConcept C2777930144 @default.
• W2571259238 hasConcept C2781182431 @default.
• W2571259238 hasConcept C71924100 @default.
• W2571259238 hasConcept C86803240 @default.
• W2571259238 hasConcept C90924648 @default.
• W2571259238 hasConceptScore W2571259238C121608353 @default.
• W2571259238 hasConceptScore W2571259238C126322002 @default.
• W2571259238 hasConceptScore W2571259238C143998085 @default.
• W2571259238 hasConceptScore W2571259238C146357865 @default.
• W2571259238 hasConceptScore W2571259238C151730666 @default.
• W2571259238 hasConceptScore W2571259238C2775999482 @default.
• W2571259238 hasConceptScore W2571259238C2776256026 @default.
• W2571259238 hasConceptScore W2571259238C2777930144 @default.
• W2571259238 hasConceptScore W2571259238C2781182431 @default.
• W2571259238 hasConceptScore W2571259238C71924100 @default.
• W2571259238 hasConceptScore W2571259238C86803240 @default.
• W2571259238 hasConceptScore W2571259238C90924648 @default.
• W2571259238 hasIssue "1" @default.
• W2571259238 hasLocation W25712592381 @default.
• W2571259238 hasOpenAccess W2571259238 @default.
• W2571259238 hasPrimaryLocation W25712592381 @default.
• W2571259238 hasRelatedWork W2388931413 @default.
• W2571259238 hasRelatedWork W2389744545 @default.
• W2571259238 hasRelatedWork W2400217987 @default.
• W2571259238 hasRelatedWork W2403361534 @default.
• W2571259238 hasRelatedWork W2406962104 @default.
• W2571259238 hasRelatedWork W2465910797 @default.
• W2571259238 hasRelatedWork W2765285169 @default.
• W2571259238 hasRelatedWork W2801241205 @default.
• W2571259238 hasRelatedWork W3171615116 @default.
• W2571259238 hasRelatedWork W4200188553 @default.
• W2571259238 hasVolume "12" @default.
• W2571259238 isParatext "false" @default.
• W2571259238 isRetracted "false" @default.
• W2571259238 magId "2571259238" @default.
• W2571259238 workType "article" @default.